Within the context of neuromyelitis optica (NMOSD), in vitro and ex vivo BBB models demonstrated that blocking IL-6 suppressed the NMO-IgG-induced transmigration of T cells and barrier dysfunction. This evidence concerns the gene IL6 and neuromyelitis optica.